Add BrightSurf on Google Email

Burness


First controlled malaria infection trial in Africa paves way for drug and vaccine development

A groundbreaking study in Tanzania successfully infects volunteers with malaria in a controlled laboratory setting, paving the way for accelerated development of new treatments. The innovative PfSPZ Challenge method eliminates the need for live mosquitoes, reducing costs and increasing accessibility to malaria research and treatment.

SourceBurness·JournalAmerican Journal of Tropical Medicine and Hygiene·DateJul 28, 2014

May research highlights from American Journal of Tropical Medicine and Hygiene

Researchers have developed a new rapid diagnostic test for worm infections that provides substantial improvement over the current standard. The test is expected to be more sensitive and easier to use than existing methods, and will help guide public health efforts to eliminate lymphatic filariasis. Lymphatic filariasis affects approxim...

SourceBurness·JournalAmerican Journal of Tropical Medicine and Hygiene·DateMay 20, 2013

TB, HIV and malaria vaccine research gets major boost

The Bill & Melinda Gates Foundation has awarded a $2.9 million grant to Aeras, Oxford University, and Okairos to develop novel vaccines against tuberculosis, HIV, and malaria. The collaboration aims to create scalable methods for large-scale production of multiple chimpanzee adenovirus vector constructs.

SourceBurness·DateMay 7, 2013